Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21)

Oncogene. 1995 Sep 21;11(6):1133-7.

Abstract

The FUS gene, which maps to 16p11, is fused to the CHOP gene in the t(12;16) (q13;p11) that characterizes myxoid liposarcomas (MLS) and to the ERG gene in acute myeloid leukemia (AML) with t(16;21) (p11;q22). In the present study we have mapped the breakpoints within FUS in 13 MLS with t(12;16) and in one AML with t(16;21). This region of FUS is about 3.9 kb and contains four exons. The breakpoints clustered to two zones (1 and 2). A strong association was found between the two known types of FUS/CHOP transcripts and the genomic localization of the breakpoints. In all cases expressing only type I or both type I and II FUS/CHOP transcript the genomic breakpoints mapped to zone 1. In all cases expressing only the type II transcript the breakpoints occurred in zone 2. The breakpoint in the AML case was in zone 1, suggesting that in-frame fusion transcripts are selected by similar mechanisms in both MLS and AML.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • CCAAT-Enhancer-Binding Proteins*
  • Chromosome Mapping
  • Chromosomes, Human, Pair 12*
  • Chromosomes, Human, Pair 16*
  • Chromosomes, Human, Pair 21*
  • DNA-Binding Proteins / genetics
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Liposarcoma, Myxoid / genetics*
  • Molecular Sequence Data
  • Neoplasm Proteins / genetics*
  • Polymerase Chain Reaction
  • RNA-Binding Protein FUS
  • Ribonucleoproteins / genetics*
  • Transcription Factor CHOP
  • Transcription Factors / genetics
  • Translocation, Genetic*

Substances

  • CCAAT-Enhancer-Binding Proteins
  • DDIT3 protein, human
  • DNA-Binding Proteins
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Neoplasm Proteins
  • RNA-Binding Protein FUS
  • Ribonucleoproteins
  • Transcription Factors
  • Transcription Factor CHOP